Home > Financial Ratios > BIOCON

BIOCON
Core EBITDA Growth

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -13.185.0544.2132.2814.45

What is the latest Core EBITDA Growth ratio of BIOCON ?

The latest Core EBITDA Growth ratio of BIOCON is -13.18 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-13.18
Mar20255.05
Mar202444.21
Mar202332.28
Mar202214.45

How is Core EBITDA Growth of BIOCON Trending?

Years Core EBITDA Growth % Change
Mar2026 -13.18
Negative
Mar2025 5.05
-88.58
Mar2024 44.21
36.96
Mar2023 32.28
123.39
Mar2022 14.45 -

Other Financial Ratios of BIOCON


Compare Core EBITDA Growth ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹62,743.5 Cr -1.5% -7.1% 4.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,398.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹248,664.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,738.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹110,794.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,749.4 Cr 0.9% 0% -11% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.5%

-7.1%

4.1%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses